Corbus Pharmaceuticals Holdings, Inc. Interest Payable, Current
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Interest Payable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2025-03-11
- 2024-12-31: Interest Payable, Current $0.00.
- 2024-09-30: Interest Payable, Current $0.00.
- 2024-06-30: Interest Payable, Current $1.53M.
- 2024-03-31: Interest Payable, Current $1.45M.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.53M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.45M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.34M 10-K · filed 2025-03-11 | $1.34M 10-K · filed 2024-03-12 |
| 2023-09-30 | $1.22M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.11M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $916.11K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $965.54K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $670.72K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $607.49K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $525.11K 10-K · filed 2023-03-07 | |
| 2013-12-31 | $77.14K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |